Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus.

Menzin J, Marton JP, Meyers JL, Carson RT, Rothermel CD, Friedman M.

Am J Infect Control. 2010 Feb;38(1):44-9. doi: 10.1016/j.ajic.2009.04.287. Epub 2009 Sep 17.

PMID:
19762120
2.

Costs of skin and skin structure infections due to Staphylococcus aureus: an analysis of managed-care claims.

Marton JP, Jackel JL, Carson RT, Rothermel CD, Friedman M, Menzin J.

Curr Med Res Opin. 2008 Oct;24(10):2821-8. doi: 10.1185/03007990802365169 . Epub 2008 Aug 28.

PMID:
18759996
3.

Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.

Zervos M, Martinez FJ, Amsden GW, Rothermel CD, Treadway G.

Int J Antimicrob Agents. 2007 Jan;29(1):56-61.

PMID:
17189096
4.
5.

Comparison of azithromycin and cefadroxil for the treatment of uncomplicated skin and skin structure infections.

Jennings MB, McCarty JM, Scheffler NM, Puopolo AD, Rothermel CD.

Cutis. 2003 Sep;72(3):240-4.

PMID:
14533837
6.

High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.

Arrieta A, Arguedas A, Fernandez P, Block SL, Emperanza P, Vargas SL, Erhardt WA, de Caprariis PJ, Rothermel CD.

Antimicrob Agents Chemother. 2003 Oct;47(10):3179-86.

8.

Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale.

Rothermel CD.

Curr Ther Res Clin Exp. 2003;64(Suppl 1):4-15. doi: 10.1016/j.curtheres.2003.09.004.

9.

A pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in children.

Arguedas A, Loaiza C, Perez A, Gutierrez A, Herrera ML, Rothermel CD.

Curr Ther Res Clin Exp. 2003;64:16-29. doi: 10.1016/j.curtheres.2003.09.005.

10.

Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States.

Kaplan EL, Rothermel CD, Johnson DR.

Pediatrics. 1998 Jan;101(1 Pt 1):86-8.

PMID:
9417157
11.

Chlamydia trachomatis-induced production of interleukin-1 by human monocytes.

Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T.

Infect Immun. 1989 Sep;57(9):2705-11.

12.

Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages.

Murray HW, Szuro-Sudol A, Wellner D, Oca MJ, Granger AM, Libby DM, Rothermel CD, Rubin BY.

Infect Immun. 1989 Mar;57(3):845-9.

13.
14.

Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.

Murray HW, Gellene RA, Libby DM, Rothermel CD, Rubin BY.

J Immunol. 1985 Oct;135(4):2374-7.

PMID:
3928746
15.
17.

Lymphokine enhances oxygen-independent activity against intracellular pathogens.

Murray HW, Byrne GI, Rothermel CD, Cartelli DM.

J Exp Med. 1983 Jul 1;158(1):234-9.

18.

Differential susceptibility of chlamydiae to exogenous fibroblast interferon.

Byrne GI, Rothermel CD.

Infect Immun. 1983 Feb;39(2):1004-5.

19.

Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells).

Rothermel CD, Byrne GI, Havell EA.

Infect Immun. 1983 Jan;39(1):362-70.

Supplemental Content

Loading ...
Support Center